EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ANNX: Annexon Inc

17 Sep 26 09:04
LAST:

4.044

CHANGE:
 0.11		OPEN:
4.044		HIGH:
4.044		ASK:
0.000		VOLUME:
970
CHG(%):
2.91		PREV:
3.930		LOW:
4.044		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Sep 264.0444.0444.0444.044970
16 Sep 263.9104.0003.8753.9304.52M
15 Sep 263.9303.9753.7903.9202.96M
14 Sep 263.9704.0353.8803.9502.9M
11 Sep 264.1954.1953.9203.9403.94M
10 Sep 264.3304.3304.0404.1404.2M
09 Sep 264.6004.6604.3404.3705.53M
08 Sep 264.7604.7854.6404.6702.14M
04 Sep 264.8104.9054.7904.8701.23M
03 Sep 264.9305.0404.7654.8402.31M

PROFILE

Name:Annexon Inc
About:Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Sector:Healthcare
Industry:Biotechnology
Address:1400 Sierra Point Parkway, Brisbane, CA, United States, 94005
Website:https://www.annexonbio.com
CUSIP:03589W102
CIK:0001528115
ISIN:US03589W1027
FIGI:BBG007QVDFG2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-3.14 
Forward P/E:-6.46 
PEG Ratio:-0.07 
Price to Book:4.73 
Return on Assets:-0.37 
Return on Equity:-0.67 
EPS Ratio:-1.20 
Shares:163.84M 
Market Cap:662.64M 

TECHNICAL INDICATORS

MA5:3.962.2%
MA10:4.275.5%
MA20:4.6615.1%
MA50:5.1126.5%
MA100:5.2529.9%
MA200:5.3933.2%
STO9:12.63 
STO14:9.68 
RSI14:12.66 
WPR14:-88.15 
MTM14:-0.93
ROC14:-0.19 
ATR:0.22 
Week High:4.337.1%
Week Low:3.796.7%
Month High:5.5938.2%
Month Low:3.7933.2%
Year High:7.1877.5%
Year Low:2.5061.8%
Volatility:12.54